rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8-9 Pt 1
|
pubmed:dateCreated |
2006-10-20
|
pubmed:abstractText |
Imatinib (Gleevec) is a tyrosine kinase inhibitor used to treat chronic myeloid leukemia. We describe a case of drug reaction with eosinophilia and systemic symptoms (DRESS) after institution of treatment with imatinib.
|
pubmed:language |
fre
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0151-9638
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
133
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
686-8
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:17053739-Aged,
pubmed-meshheading:17053739-Antineoplastic Agents,
pubmed-meshheading:17053739-Bacteremia,
pubmed-meshheading:17053739-Drug Eruptions,
pubmed-meshheading:17053739-Eosinophilia,
pubmed-meshheading:17053739-Exanthema,
pubmed-meshheading:17053739-Female,
pubmed-meshheading:17053739-Humans,
pubmed-meshheading:17053739-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:17053739-Piperazines,
pubmed-meshheading:17053739-Protein Kinase Inhibitors,
pubmed-meshheading:17053739-Protein-Tyrosine Kinases,
pubmed-meshheading:17053739-Pruritus,
pubmed-meshheading:17053739-Pyrimidines,
pubmed-meshheading:17053739-Staphylococcal Infections,
pubmed-meshheading:17053739-Syndrome
|
pubmed:articleTitle |
[Drug reaction with eosinophilia and systemic symptoms (DRESS) following imatinib therapy].
|
pubmed:affiliation |
Service de Dermatologie et Vénéréologie, Hôpital Sud, Amiens, France. patricialenouail@yahoo.fr
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|